139 related articles for article (PubMed ID: 19199612)
1. In vitro imaging and in vivo liver targeting with carbohydrate capped quantum dots.
Kikkeri R; Lepenies B; Adibekian A; Laurino P; Seeberger PH
J Am Chem Soc; 2009 Feb; 131(6):2110-2. PubMed ID: 19199612
[TBL] [Abstract][Full Text] [Related]
2. Mannosylated semiconductor quantum dots for the labeling of macrophages.
Higuchi Y; Oka M; Kawakami S; Hashida M
J Control Release; 2008 Jan; 125(2):131-6. PubMed ID: 18045722
[TBL] [Abstract][Full Text] [Related]
3. Galactose-grafted chylomicron-mimicking emulsion: evaluation of specificity against HepG-2 and MCF-7 cell lines.
Jain V; Nath B; Gupta GK; Shah PP; Siddiqui MA; Pant AB; Mishra PR
J Pharm Pharmacol; 2009 Mar; 61(3):303-10. PubMed ID: 19222902
[TBL] [Abstract][Full Text] [Related]
4. One-pot fabrication of high-quality InP/ZnS (core/shell) quantum dots and their application to cellular imaging.
Hussain S; Won N; Nam J; Bang J; Chung H; Kim S
Chemphyschem; 2009 Jul; 10(9-10):1466-70. PubMed ID: 19514031
[TBL] [Abstract][Full Text] [Related]
5. PEGylated liposome coated QDs/mesoporous silica core-shell nanoparticles for molecular imaging.
Pan J; Wan D; Gong J
Chem Commun (Camb); 2011 Mar; 47(12):3442-4. PubMed ID: 21301716
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the stability and biological functionalities of quantum dots via compact multifunctional ligands.
Susumu K; Uyeda HT; Medintz IL; Pons T; Delehanty JB; Mattoussi H
J Am Chem Soc; 2007 Nov; 129(45):13987-96. PubMed ID: 17956097
[TBL] [Abstract][Full Text] [Related]
7. Probing lectin and sperm with carbohydrate-modified quantum dots.
Robinson A; Fang JM; Chou PT; Liao KW; Chu RM; Lee SJ
Chembiochem; 2005 Oct; 6(10):1899-905. PubMed ID: 16149042
[TBL] [Abstract][Full Text] [Related]
8. Characterization of multivalent lactose quantum dots and its application in carbohydrate-protein interactions study and cell imaging.
Yang Y; Yu M; Yan TT; Zhao ZH; Sha YL; Li ZJ
Bioorg Med Chem; 2010 Jul; 18(14):5234-40. PubMed ID: 20566293
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive imaging of quantum dots in mice.
Ballou B; Lagerholm BC; Ernst LA; Bruchez MP; Waggoner AS
Bioconjug Chem; 2004; 15(1):79-86. PubMed ID: 14733586
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of a non-carbohydrate targeting platform for lysosomal proteins.
Stefano JE; Hou L; Honey D; Kyazike J; Park A; Zhou Q; Pan CQ; Edmunds T
J Control Release; 2009 Apr; 135(2):113-8. PubMed ID: 19146893
[TBL] [Abstract][Full Text] [Related]
11. Stable functionalized PEGylated quantum dots micelles with a controlled stoichiometry.
Amela-Cortes M; Roullier V; Wolpert C; Neubauer S; Kessler H; Bedel O; Mignani S; Marchi-Artzner V
Chem Commun (Camb); 2011 Jan; 47(4):1246-8. PubMed ID: 21103558
[TBL] [Abstract][Full Text] [Related]
12. Selective quantification of carnitine enantiomers using chiral cysteine-capped CdSe(ZnS) quantum dots.
Carrillo-Carrión C; Cárdenas S; Simonet BM; Valcárcel M
Anal Chem; 2009 Jun; 81(12):4730-3. PubMed ID: 19462974
[TBL] [Abstract][Full Text] [Related]
13. Study of carbohydrate-protein interactions using glyco-QDs with different fluorescence emission wavelengths.
Yang Y; Cui XK; Zhong M; Li ZJ
Carbohydr Res; 2012 Nov; 361():189-94. PubMed ID: 23026714
[TBL] [Abstract][Full Text] [Related]
14. PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake.
Mok H; Bae KH; Ahn CH; Park TG
Langmuir; 2009 Feb; 25(3):1645-50. PubMed ID: 19117377
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of a pegylated derivative of 3-(1,2,3,6-tetrahydro-pyridin-4yl)-1H-indole (IDT199): a high affinity SERT ligand for conjugation to quantum dots.
Tomlinson ID; Warnerment MR; Mason JN; Vergne MJ; Hercules DM; Blakely RD; Rosenthal SJ
Bioorg Med Chem Lett; 2007 Oct; 17(20):5656-60. PubMed ID: 17766114
[TBL] [Abstract][Full Text] [Related]
16. An investigation into the potential for different surface-coated quantum dots to cause oxidative stress and affect macrophage cell signalling in vitro.
Clift MJ; Boyles MS; Brown DM; Stone V
Nanotoxicology; 2010 Jun; 4(2):139-49. PubMed ID: 20795892
[TBL] [Abstract][Full Text] [Related]
17. Controlling the reactivity of ampiphilic quantum dots in biological assays through hydrophobic assembly of custom PEG derivatives.
Warnement MR; Tomlinson ID; Chang JC; Schreuder MA; Luckabaugh CM; Rosenthal SJ
Bioconjug Chem; 2008 Jul; 19(7):1404-13. PubMed ID: 18529022
[TBL] [Abstract][Full Text] [Related]
18. Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain.
Kato S; Itoh K; Yaoi T; Tozawa T; Yoshikawa Y; Yasui H; Kanamura N; Hoshino A; Manabe N; Yamamoto K; Fushiki S
Nanotechnology; 2010 Aug; 21(33):335103. PubMed ID: 20660952
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications.
Yong KT; Roy I; Ding H; Bergey EJ; Prasad PN
Small; 2009 Sep; 5(17):1997-2004. PubMed ID: 19466710
[TBL] [Abstract][Full Text] [Related]
20. Oligomeric PEG-phospholipids for solubilization and stabilization of fluorescent nanocrystals in water.
Travert-Branger N; Dubois F; Carion O; Carrot G; Mahler B; Dubertret B; Doris E; Mioskowski C
Langmuir; 2008 Apr; 24(7):3016-9. PubMed ID: 18303920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
